Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5

CARBONI, NICOLA;Floris M;Mateddu A;Porcu M;Marrosu G;Solla E;COCCO, ELEONORA;Mura M;Marini S;Maioli MA;Piras R;Aste R;MARROSU, MARIA GIOVANNA

2011-01-01

---

Abstract

Abstract INTRODUCTION: Familial dilated cardiomyopathy with conduction system defects variably associated with skeletal muscle abnormalities is frequently caused by LMNA gene mutations. METHODS: A family affected by cardiac abnormalities, either isolated or variably associated with skeletal muscle compromise, was identified. LMNA gene analysis was applied to all family members. RESULTS: A novel intron 5 (c.937-11 C > G) mutation was identified. mRNA transcription analysis was subsequently performed, and cDNA was obtained from mutated patients. It displayed an aberrant splice product featuring the insertion of 40 nucleotides from intron 5, leading to a frameshift. Computational predictions identified a cryptic splice site 40 bp upstream from the canonical site; this alternative splicing event was elicited by intronic mutation, which seems to interfere with the polypyrimidine tract of the canonical site. CONCLUSIONS: We have described the first mutation on the LMNA gene interfering with the polypyrimidine tract. Our findings underline the importance of including introns in the search for mutations.